Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
mRNA stabilization is not a single molecule or receptor but a complex, essential cellular process regulating the lifespan and availability of messenger RNAs, ultimately impacting protein production. Mechanisms controlling mRNA stability include the action of RNA-binding proteins that bind cis-regulatory elements (such as AU-rich elements) within the mRNA, chemical modifications like methylation (e.g., m^7G cap, m^6Am, m^5C, pseudouridine) that enhance mRNA integrity, and sequestration of mRNA within intracellular structures like stress granules[2][3][4][5]. Dysregulated mRNA stability is implicated in various diseases because it can alter protein expression profiles, affecting processes such as stress response, proliferation, and apoptosis[1][4][6]. However, "mRNA stabilization" is not a concrete canonical drug target but rather a regulatory process manipulated by numerous trans-acting factors and pathways.
Stabilization of mRNA via RNA-binding proteins; Chemical modification of RNA (e.g., methylation, pseudouridylation); Inhibition of mRNA degradation enzymes
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on mRNA stabilization.